Literature DB >> 12496353

A model for a smallpox-vaccination policy.

Samuel A Bozzette1, Rob Boer, Vibha Bhatnagar, Jennifer L Brower, Emmett B Keeler, Sally C Morton, Michael A Stoto.   

Abstract

BACKGROUND: The new reality of biologic terrorism and warfare has ignited a debate about whether to reintroduce smallpox vaccination.
METHODS: We developed scenarios of smallpox attacks and built a stochastic model of outcomes under various control policies. We conducted a systematic literature review and estimated model parameters on the basis of European and North American outbreaks since World War II. We assessed the trade-offs between vaccine-related harms and benefits.
RESULTS: Nations or terrorists possessing a smallpox weapon could feasibly mount attacks that vary with respect to tactical complexity and target size, and patterns of spread can be expected to vary according to whether index patients are hospitalized early. For acceptable results, vaccination of contacts must be accompanied by effective isolation. Vaccination of contacts plus isolation is expected to result in 7 deaths (from vaccine or smallpox) in a scenario involving the release of variola virus from a laboratory, 19 deaths in a human-vector scenario, 300 deaths in a building-attack scenario, 2735 deaths in a scenario involving a low-impact airport attack, and 54,729 deaths in a scenario involving a high-impact airport attack. Immediate vaccination of the public in an attacked region would provide little additional benefit. Prior vaccination of health care workers, who would be disproportionately affected, would save lives in large local or national attacks but would cause 25 deaths nationally. Prior vaccination of health care workers and the public would save lives in a national attack but would cause 482 deaths nationally. The expected net benefits of vaccination depend on the assessed probability of an attack. Prior vaccination of health care workers would be expected to save lives if the probability of a building attack exceeded 0.22 or if the probability of a high-impact airport attack exceeded 0.002. The probability would have to be much higher to make vaccination of the public life-saving.
CONCLUSIONS: The analysis favors prior vaccination of health care workers unless the likelihood of any attack is very low, but it favors vaccination of the public only if the likelihood of a national attack or of multiple attacks is high. Copyright 2003 Massachusetts Medical Society

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12496353     DOI: 10.1056/NEJMsa025075

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  43 in total

1.  Group interest versus self-interest in smallpox vaccination policy.

Authors:  Chris T Bauch; Alison P Galvani; David J D Earn
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-14       Impact factor: 11.205

Review 2.  Ethical challenges in preparing for bioterrorism: barriers within the health care system.

Authors:  Matthew K Wynia; Lawrence O Gostin
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

3.  Population-level differences in disease transmission: a Bayesian analysis of multiple smallpox epidemics.

Authors:  Bret D Elderd; Greg Dwyer; Vanja Dukic
Journal:  Epidemics       Date:  2013-07-25       Impact factor: 4.396

4.  Poxy models and rash decisions.

Authors:  Ben Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

5.  Bioterrorism preparedness: the smallpox vaccine debate.

Authors:  Salah S Qutaishat; John L Olson
Journal:  Clin Med Res       Date:  2003-04

6.  Comparison of smallpox outbreak control strategies using a spatial metapopulation model.

Authors:  I M Hall; J R Egan; I Barrass; R Gani; S Leach
Journal:  Epidemiol Infect       Date:  2007-01-12       Impact factor: 2.451

7.  Uncertainty in predictions of disease spread and public health responses to bioterrorism and emerging diseases.

Authors:  Bret D Elderd; Vanja M Dukic; Greg Dwyer
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-09       Impact factor: 11.205

8.  Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations.

Authors:  Shuji Hatakeyama; Kyoji Moriya; Masayuki Saijo; Yuji Morisawa; Ichiro Kurane; Kazuhiko Koike; Satoshi Kimura; Shigeru Morikawa
Journal:  Clin Diagn Lab Immunol       Date:  2005-04

9.  Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity.

Authors:  M Kathryn Liszewski; Marilyn K Leung; Richard Hauhart; Celia J Fang; Paula Bertram; John P Atkinson
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

10.  Treating relapsing multiple sclerosis with subcutaneous versus intramuscular interferon-beta-1a: modelling the clinical and economic implications.

Authors:  Shien Guo; Duygu Bozkaya; Alexandra Ward; Judith A O'Brien; Khajak Ishak; Randy Bennett; Ahmad Al-Sabbagh; Dennis M Meletiche
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.